Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Arpad Szallasi & Mohamed Sheta. (2012) Targeting TRPV1 for pain relief: limits, losers and laurels. Expert Opinion on Investigational Drugs 21:9, pages 1351-1369.
Read now
Read now
Delia Preti, Arpad Szallasi & Riccardo Patacchini. (2012) TRP channels as therapeutic targets in airway disorders: a patent review. Expert Opinion on Therapeutic Patents 22:6, pages 663-695.
Read now
Read now
Eric A Voight & Michael E Kort. (2010) Transient receptor potential vanilloid-1 antagonists: a survey of recent patent literature. Expert Opinion on Therapeutic Patents 20:9, pages 1107-1122.
Read now
Read now
K. R. Vinod, Saurabh Chandra & Sharad K. Sharma. (2010) Evaluation of 5-aminoisoquinoline (5-AIQ), a novel PARP-1 inhibitor for genotoxicity potential in vitro and in vivo. Toxicology Mechanisms and Methods 20:2, pages 90-95.
Read now
Read now
József Lázár, Laxmikant Gharat, Neelima Khairathkar-Joshi, Peter M Blumberg & Arpad Szallasi. (2009) Screening TRPV1 antagonists for the treatment of pain: lessons learned over a decade. Expert Opinion on Drug Discovery 4:2, pages 159-180.
Read now
Read now
Articles from other publishers (27)
Chunxia Liu, Ruoyang Miao, Faisal Raza, Hai Qian & Xin Tian. (2023) Research progress and challenges of TRPV1 channel modulators as a prospective therapy for diabetic neuropathic pain. European Journal of Medicinal Chemistry 245, pages 114893.
Crossref
Crossref
Qianqian Liang, Zhen Qiao, Qiqi Zhou, Dengqi Xue, KeWei Wang & Liming Shao. (2022)
Discovery of Potent and Selective Transient Receptor Potential Vanilloid 1 (TRPV1) Agonists with Analgesic Effects
In Vivo
Based on the Functional Conversion Induced by Altering the Orientation of the Indazole Core
. Journal of Medicinal Chemistry 65:17, pages 11658-11678.
Crossref
Crossref
Muzaffar Iqbal, Essam A. Ali, Mohd Abul Kalam, Sheikh F. Ahmad & Rashad Al-Salahi. (2022) Quantitative Determination of 5-Aminoisoquinoline, a PARP-1 Inhibitor by UPLC-MS/MS: In Silico ADME Profile and In Vitro Metabolic Stability Study. Applied Sciences 12:12, pages 5998.
Crossref
Crossref
Gustavo José Vasco Pereira, Maurício Temotheo Tavares, Ricardo Alexandre Azevedo, Barbara Behr Martins, Micael Rodrigues Cunha, Rajesh Bhardwaj, Yara Cury, Vanessa Olzon Zambelli, Euzébio Guimarães Barbosa, Matthias A. Hediger & Roberto Parise-Filho. (2019) Capsaicin-like analogue induced selective apoptosis in A2058 melanoma cells: Design, synthesis and molecular modeling. Bioorganic & Medicinal Chemistry 27:13, pages 2893-2904.
Crossref
Crossref
Iziara F. Florentino, Daiany P.B. Silva, Carina Sofia Cardoso, Ricardo Menegatti, Flávio S. de Carvalho, Luciano M. Lião, Paulo M. Pinto, Steve Peigneur, Elson A. Costa & Jan Tytgat. (2019) Antinociceptive effects of new pyrazoles compounds mediated by the ASIC-1α channel, TRPV-1 and μMOR receptors. Biomedicine & Pharmacotherapy 115, pages 108915.
Crossref
Crossref
Magdalene M Moran & Arpad Szallasi. (2017)
Targeting nociceptive
transient receptor potential
channels to treat chronic pain: current state of the field
. British Journal of Pharmacology 175:12, pages 2185-2203.
Crossref
Crossref
Yelena Mostinski, Gilad Noy, Rakesh Kumar, Dmitry Tsvelikhovsky & Avi Priel. (2017) Tricyclic Spirolactones as Modular TRPV1 Synthetic Agonists. ACS Chemical Neuroscience 8:8, pages 1688-1696.
Crossref
Crossref
Ruben Vardanyan & Victor Hruby. 2016. Synthesis of Best-Seller Drugs. Synthesis of Best-Seller Drugs
15
64
.
William Rea & Kalpana Patel. 2014. Reversibility of Chronic Disease and Hypersensitivity,Volume 2. Reversibility of Chronic Disease and Hypersensitivity,Volume 2
99
250
.
Jill-Desiree Brederson, Philip R. Kym & Arpad Szallasi. (2013) Targeting TRP channels for pain relief. European Journal of Pharmacology 716:1-3, pages 61-76.
Crossref
Crossref
M. Führer, H. Vogelsang & J. Hammer. (2011) A placebo-controlled trial of an oral capsaicin load in patients with functional dyspepsia. Neurogastroenterology & Motility 23:10, pages 918-e397.
Crossref
Crossref
Peter Holzer. (2011) Transient receptor potential (TRP) channels as drug targets for diseases of the digestive system. Pharmacology & Therapeutics 131:1, pages 142-170.
Crossref
Crossref
Rong Xia, Kim Dekermendjian, Elke Lullau & Niek Dekker. 2011. Transient Receptor Potential Channels. Transient Receptor Potential Channels
637
665
.
Natalie A. Hawryluk, Jeffrey E. Merit, Alec D. Lebsack, Bryan J. Branstetter, Michael D. Hack, Nadia Swanson, Hong Ao, Michael P. Maher, Anindya Bhattacharya, Qi Wang, Jamie M. Freedman, Brian P. Scott, Alan D. Wickenden, Sandra R. Chaplan & J. Guy Breitenbucher. (2010) Discovery and synthesis of 6,7,8,9-tetrahydro-5H-pyrimido-[4,5-d]azepines as novel TRPV1 antagonists. Bioorganic & Medicinal Chemistry Letters 20:23, pages 7137-7141.
Crossref
Crossref
Alec D. Lebsack, Jason C. Rech, Bryan J. Branstetter, Natalie A. Hawryluk, Jeffrey E. Merit, Brett Allison, Raymond Rynberg, Johnathan Buma, Michele Rizzolio, Nadia Swanson, Hong Ao, Michael P. Maher, Michelle Herrmann, Jamie Freedman, Brian P. Scott, Lin Luo, Anindya Bhattacharya, Qi Wang, Sandra R. Chaplan, Alan D. Wickenden & J. Guy Breitenbucher. (2010) 1,2-Diamino-ethane-substituted-6,7,8,9-tetrahydro-5H-pyrimido[4,5-d]azepines as TRPV1 antagonists with improved properties. Bioorganic & Medicinal Chemistry Letters 20:23, pages 7142-7146.
Crossref
Crossref
Natalie A. Hawryluk & Nicholas I. Carruthers. 2010. Vanilloid Receptor TRPV1 in Drug Discovery. Vanilloid Receptor TRPV1 in Drug Discovery
311
324
.
Arthur Gomtsyan. 2010. Vanilloid Receptor TRPV1 in Drug Discovery. Vanilloid Receptor TRPV1 in Drug Discovery
293
310
.
Yi Liu & Ning Qin. 2009. Enzyme Inhibition in Drug Discovery and Development. Enzyme Inhibition in Drug Discovery and Development
669
717
.
Philip R. Kym, Michael E. Kort & Charles W. Hutchins. (2009) Analgesic potential of TRPV1 antagonists. Biochemical Pharmacology 78:3, pages 211-216.
Crossref
Crossref
Marcello Trevisani & Arpad Szallasi. 2009. Peripheral Receptor Targets for Analgesia. Peripheral Receptor Targets for Analgesia
175
213
.
Aled M Edwards, Chas Bountra, David J Kerr & Timothy M Willson. (2009) Open access chemical and clinical probes to support drug discovery. Nature Chemical Biology 5:7, pages 436-440.
Crossref
Crossref
Shang-Gao Liao, Hua-Dong Chen & Jian-Min Yue. (2009) Plant Orthoesters. Chemical Reviews 109:3, pages 1092-1140.
Crossref
Crossref
Neelima Khairatkar-Joshi & Arpad Szallasi. (2009) TRPV1 antagonists: the challenges for therapeutic targeting. Trends in Molecular Medicine 15:1, pages 14-22.
Crossref
Crossref
Martin J. Gunthorpe & Boris A. Chizh. (2009) Clinical development of TRPV1 antagonists: targeting a pivotal point in the pain pathway. Drug Discovery Today 14:1-2, pages 56-67.
Crossref
Crossref
Alec D. Lebsack, Bryan J. Branstetter, Michael D. Hack, Wei Xiao, Matthew L. Peterson, Nadia Nasser, Michael P. Maher, Hong Ao, Anindya Bhattacharya, Mena Kansagara, Brian P. Scott, Lin Luo, Raymond Rynberg, Michele Rizzolio, Sandra R. Chaplan, Alan D. Wickenden & J. Guy Breitenbucher. (2009) Identification and synthesis of 2,7-diamino-thiazolo[5,4-d]pyrimidine derivatives as TRPV1 antagonists. Bioorganic & Medicinal Chemistry Letters 19:1, pages 40-46.
Crossref
Crossref
Peter Holzer. 2009. Sensory Nerves. Sensory Nerves
283
332
.
Stuart J. Conway. (2008) TRPing the switch on pain: an introduction to the chemistry and biology of capsaicin and TRPV1. Chemical Society Reviews 37:8, pages 1530.
Crossref
Crossref